Skip to content
Prime Global Forge World

Zimbabwe Rejects ‘One-Sided’ American Health Aid Agreement Due to Information Fears

Medical aid illustration
The proposed American financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has rejected a substantial US health deal valued at 367 million US dollars (£272m) over five years due to Washington's request for sensitive information.

The decision came to light following a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

A government spokesperson later stated that the United States was seeking genetic material for research and commercial purposes while was unwilling to share the resulting advantages from future vaccines.

"We are forced to start the challenging and unfortunate task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A medical body in Zimbabwe has urged further dialogue to reach a deal suitable to all parties so the nation's vital HIV programme can be sustained.

Broader Context

This rejection comes after a similar case in neighbouring Kenya, where a court suspended a related deal with the US after concerns were filed about the safety of Kenyans' health data.

After returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.

USAID had managed assistance for the American government, but Trump stated its spending was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and responsibility.

Based on statements, Sixteen nations in Africa have so far signed these new health pacts, representing over $18.3bn in committed funds.

Details of the Declined Deal

The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this cooperation might have yielded extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," Tremont said.

However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".

"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no corresponding assurance of access to any medical innovations – like new medicines or tests – that could result from that provided information," Mangwana explained.

"Put simply, our country would supply the raw materials for medical research with no certainty that the resulting innovations would be accessible to our people should a new health crisis arise."

Sovereignty and Global Health

He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were undermining systems previously set up via the global health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing framework created to manage future pandemics.

"This mechanism is intended to ensure that when a nation contributes its information, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."

Zimbabwe's reservations over the US deal "are not meant as opposition to America," Mangwana stressed.

"We are open to continued dialogue with our US partners on how future co-operation might be structured in a way that honours the sovereignty and dignity of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but urged that talks need to persist considering much of the nation's Aids initiatives relied on external financing.

"In cases where technical issues arise, including those relating to data governance or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," it said.

The situation highlights the complex debate between accepting much-needed international aid and protecting a country's data in an increasingly interconnected world.

The writer

James Gaines

Lena Voss is a tech journalist and innovation strategist with over a decade of experience in covering emerging technologies.

Prime Global Forge World

Type to search articles.